An offer to HIMSS: the eight maturity models computed continuously from real operational data — 50 signals, 68 criteria — telling an organisation where it stands, what to do next, and assembling the evidence for formal HIMSS validation.
This is an offer to HIMSS: a live maturity meter built into a working health and care platform, reading the eight HIMSS maturity models continuously from real operational data, telling an organisation where it stands and what to do next — and assembling the evidence pack for formal HIMSS validation. It is built. This document proposes the partnership around it.
The one thing to be clear about before anything else. commvita measures validation readiness and assembles evidence. It does not award a stage, and the product says so on the screen. Formal staging is HIMSS’s, through HIMSS validation. Everything below is designed to make that validation better attended, better evidenced and more frequent — never to substitute for it.
commvita is a connected care platform: one person-centred record used across primary care, hospital, community nursing, mental health, adult and children’s social care, pharmacy, dentistry and urgent care — with the governance, board assurance and information-governance record built into the same product rather than bought alongside it.
A person with a long-term condition, a care package and a mental-health team is, in most health economies, nine records that occasionally send each other letters. commvita is one application over one store, so the settings write to the same record.
Open standards, self-hosted, no vendor lock. The base edition is £1 per instance with optional support — deliberately priced so that owning your own infrastructure is not a budget decision. Jurisdiction is configuration, never a release.
Every claim in the product is measured, cited, or labelled unverified. Where a figure cannot be computed it is returned as unavailable with the reason, not as a zero. That discipline is why a maturity meter built on this platform can be trusted.
A maturity assessment is, today, an event. Months of evidence gathering, much of it re-keying what the operational systems already hold; a validation; a stage; and then a figure that ages quietly until the next cycle. Between cycles the organisation has no signal, and HIMSS has no visibility.
The models reach organisations that would never commission an assessment, because seeing your position costs nothing extra once the platform is running. Validation demand rises from a warmer, better-evidenced pipeline, and the licensed cockpit is a recurring revenue share rather than a one-off engagement fee.
The evidence is a by-product of running the service rather than a parallel exercise. The blocking criterion is named continuously, so improvement is a work queue rather than an annual scramble — and the validation arrives with no surprises in it.
50 signals are measured from the running platform and evaluated against 68 criteria across the eight models. A stage passes only when all of its criteria pass — there is no partial credit and no rounding up.
| Model | Criteria | What it reads |
|---|---|---|
| CCMM — continuity of care | 33 | Nine domains across the care continuum — the primary model |
| AMAM — analytics | 9 | Data governance, the clinical repository, AI readiness |
| O-EMRAM — outpatient | 5 | Community and outpatient record adoption |
| EMRAM — inpatient | 6 | Order entry, decision support, device integration, closed-loop administration |
| INFRAM — infrastructure | 5 | Security architecture, network monitoring, mobility, real-time operations |
| DIAM — digital imaging | 5 | PACS and vendor-neutral archive, structured reporting, image sharing, AI triage |
| CISOM — supply outcomes | 5 | GS1 barcoding, replenishment, product-to-patient, supply-to-outcome |
| Total | 68 | plus the Digital Health Indicator, a 0–400 roll-up across four dimensions |
A score without an action is a scoreboard. Every failing criterion returns the model it blocks, the stage it blocks, the current value, the threshold, the effort, and the specific action — and, because the meter lives inside the platform being measured, the module that would close it is one click away.
The ceiling is honest, and stated in the product. Models reach stage 6 from capability signals the platform can genuinely see. Stage 7 is deliberately reserved for a real-time external feed — radiation dose reporting, supply-chain data exchange, security and device telemetry — because module presence is not the same as an operating feed, and claiming otherwise would inflate the very models this partnership exists to protect.
The engine, the eight models, the 68 criteria, the gap recommendations and the evidence-pack assembly are shipped and running. The licensing switch is in place. The platform underneath is a real clinical and governance system, not a scoring tool looking for data.
1. A conversation about accuracy — we want the criteria checked against the published models by the people who own them. 2. Permission to name the models in-product under agreed terms. 3. A revenue-share structure for the licensed cockpit. 4. A referral path from a ready organisation into formal validation.
The criteria are our reading of the published models, and have not been reviewed by HIMSS. That is the first thing we want to fix, and it is the main reason for this conversation. Where our interpretation is wrong we would rather be corrected than shipped.
No trademark or endorsement is claimed or implied. The model names appear here to describe what the engine computes. Their use in-product is exactly what we are asking to agree.
The gauge values in this document are illustrative of the display. They are not an assessment of any organisation, and they are not a benchmark.
Stages 6 and 7 require HIMSS validation, and the product enforces that rather than describing it. A self-assessment cannot reach them in the meter, by design.
Non-SaMD. The maturity meter is an organisational measurement and improvement surface. It makes no clinical decision, and it holds no patient-identifiable data in any figure it publishes.